A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.
Document Type
Journal Article
Publication Date
7-11-2017
Journal
Leukemia & Lymphoma
DOI
10.1080/10428194.2017.1347932
APA Citation
Hill, B., Smith, M., Shelley, M., Jagadeesh, D., Dean, R., Pohlman, B., Sweetenham, J., Bolwell, B., & Smith, S. (2017). A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.. Leukemia & Lymphoma, (). http://dx.doi.org/10.1080/10428194.2017.1347932
Peer Reviewed
1
